OBJECTIVE: Determine if increased intra-abdominal pressure (IAP) alone can cause systemic hypertension in a chronic canine model. DESIGN: Evaluate effects of increase in IAP with progressive in¯ation and de¯ation of an intra-abdominal balloon on systemic blood pressure in experimental and control animals. SUBJECTS: Male dogs weighing 15 ± 25 kg underwent placement of an intra-abdominal balloon which was progressively in¯ated on a weekly basis in the experimental animals (5) over 4 weeks to 25 mmHg above baseline and kept there for an additional 2 weeks before gradual de¯ation over 2 weeks. Control animals (5) had the balloon placed but not in¯ated. Pain was controlled with osmotic analgesic pumps. MEASUREMENTS: The animals were anesthetized, blood pressure (BP) measured and blood drawn for plasma renin activity (PRA), aldosterone, atrial naturetic peptide (ANP), catecholamines, and serum sodium (Na). A right heart catheter was inserted for measuring cardiac output (CO) and pulmonary artery occlusion pressure (PAOP) at baseline, week 5 (maximal IAP) and week 7 (after balloon de¯ation). The animals were weighed and urinary bladder pressures recorded weekly before and after abdominal balloon in¯ation. RESULTS: Systolic (122 AE 3 to 155 AE 5 mmHg, P`0.05) and diastolic (82 AE 4 mmHg to 107 AE 7 mmHg, P`0.05) BP rose at 5 weeks at 25 mmHg IAP b baseline and returned to control with balloon de¯ation. Both systolic and diastolic BP rose (P`0.05) above control animals BP at 15 mmHg IAP at 2 weeks and remained elevated until abdominal decompression, at week 7. There were no signi®cant changes in net animal weight, PRA, aldosterone, ANF, catecholamines, Na, CO or PAOP. CONCLUSION: Increased IAP from progressively in¯ating an intra-abdominal balloon in dogs was associated with signi®cant increases in systolic and diastolic BP that resolved with balloon de¯ation. Increased IAP may be a cause for systemic hypertension in central obesity and pre-eclampsia.
Introduction
Central obesity, due to both subcutaneous and visceral adipose tissue, has been shown to be associated with an increased intra-abdominal pressure (IAP). 1 Pathologic conditions speci®cally associated with central, rather than peripheral, obesity such as insulin resistance, hyperinsulinemia and diabetes, altered lipid metabolism, and hypertension have been grouped together as`syndrome X' in patients with central obesity. 2 ± 5 It has been hypothesized that the hypertension of central obesity is due to hyperglycemia, insulin resistance, hyperinsulinism, and volume expansion secondary to insulin-stimulated sodium reabsorption, as well as insulin-induced increased catecholamine sensitivity. 6 ± 9 This has been refuted by others. 10 ± 17 In recent clinical and animal studies 18 ± 20 we have hypothesized that the hypertensive state associated with morbid obesity and possibly preeclampsia is due to a chronically elevated IAP.
In this study we evaluated the effects in a chronic canine model of a progressive and prolonged increase in IAP, as well as subsequent gradual abdominal decompression, upon systemic arterial pressure.
Methods

The canine model
The study was approved by the Institutional Animal Care and Use Committee (IACUC) of the Medical College of Virginia of Virginia Commonwealth University and adhered to AALAC and NIH Guidelines for care of laboratory animals. The study included 5 experimental and 5 control male mongrel dogs, weighing between 15 and 25 kg. They were anesthetized with 25 mgakg IV sodium pentothal followed by inhalation anesthesia of 1.5 ± 2% halothane. An intravenous line was inserted in a forelimb vein to allow blood sampling and delivery of normal saline for hydration during surgery. Blood samples were drawn for measurement of plasma renin activity (PRA) and aldosterone determined by radioimmunoassay (Coat-A-Count, Diagnostic Products Corp., Los Angeles, CA), atrial natriuretic peptide (ANP) by radioimmunoassay (Amerlex-M magnetic separation, Amersham, Arlington Heights, IL), catecholamines by HPLC with electrochemical detection employing an alumina extraction step with an average recovery of 62% and a dynamic linear range from 25 ± 1000 pgaml, and sodium (Na) levels with an electrolyte analyzer. The systolic (SAP) and diastolic (DAP) arterial blood pressures were measured by placing a 22-gauge needle connected to a pressure transducer into the left femoral artery distal to the inguinal ligament. A urinary bladder catheter was inserted using sterile technique for measurement of urinary bladder pressure. The protocol schema is presented in Table 1 .
A pulmonary artery catheter was inserted through a small venotomy in the right internal jugular vein and positioned in the pulmonary artery via pressure waveform monitoring. Baseline measurements of central venous pressure (CVP), pulmonary artery pressure (PAP), pulmonary artery wedge pressure (PAWP), and cardiac output (CO) were recorded. Cardiac index (CI) was calculated from the formula (CI COÂ0.112 weight 0.66 ) and systemic vascular resistance index (SVRI) from the formula: SVRI [(SAP-CVP)Â79.92aCI]. The catheter was then removed and the venotomy repaired using 6-0 prolene suture.
The peritoneal cavity was opened with a 6 cm lower paramedian incision and a sterile 6 liter polyethylene solution administration bag, which was thermally sealed at approximately 5 liters on the end opposite the¯uid administration spout, was placed into the peritoneal cavity. The spout of the balloon was brought out of the peritoneal cavity via a stab wound located approximately 1 cm below the xyphoid process. The lower abdominal incision was closed in 3 layers using a nonabsorbable mono®lament suture. A 2 cm incision was made between the animal's shoulder blades and a small subcutaneous pocket created. The balloon's spout was brought through the subcutaneous tissue to the pocket between the shoulder blades. The fascia and skin at the stab wound were closed using a nonabsorbable suture. The baseline urinary bladder pressure was measured, after which the spout of the intraperitoneal balloon was connected to a bag of sterile saline and the intraperitoneal balloon in¯ated until the urinary bladder pressure was raised to 10 mmHg above baseline. The spout of the intraperitoneal balloon was capped and returned to the pocket between the shoulder blades.
Three Alzet 1 osmotic analgesic pumps set to deliver buprenorphine at 0.72 mgad were then placed into the subcutaneous pocket between the shoulder blades and the incision was closed. This was the dose recommended by our institutional veterinarian as that which would provide adequate analgesia for this study. Lastly, an abdominal binder was placed about the animal's abdomen to prevent accommodation to the balloon and any decrease in the established abdominal pressure, which had previously occurred in the absence of the binder. The binder consisted of a standard commercial wide elastic abdominal binder. It was placed over the abdomen and attached to itself on the dorsum of the dog with a Velcro 1 fastener. This was further reinforced with adhesive tape to prevent its displacement. The animals appeared to tolerate the binder well and after a few days of adjustment made no attempt to remove them. The animals had their intravenous line removed and were allowed to recover from anesthesia. During the week between procedures and sample collection the animals were fed a standardized diet and were allowed free access to water. The animals were weighed weekly.
The animals were returned to the sterile operating room on a weekly basis for the next 3 weeks after being anesthetized and intubated as previously described. Venous blood samples were again drawn for measurement of hormones and cations. Arterial and urinary bladder pressures were measured as previously described. The experimental animals had their intraperitoneal balloon further in¯ated for each of the next three weeks, until the urinary bladder pressure had been raised to 15, 20 and 25 mmHg above 
UBP (mm Hg)* 0 0 0 0 0 0 0 blood pressure X X X X X X X hemodynamics*** X X X *UBP urinary bladder pressure above baseline pressure. **Hormones measured included plasma renin activity, aldosterone, atrial naturetic factor, epinephrine and norepinephrine. ***Hemodynamic measurements and calculations included cardiac output, cardiac index, central venous pressure, pulmonary artery pressure, pulmonary arterial occlusion pressure and systemic vascular resistance index.
Increased IAP causes hypertension in dogs GL Bloom®eld et al baseline, respectively. New osmotic analgesic pumps were placed at each operation. Control animals were treated in an identical manner with placement of an abdominal binder and insertion of the intraperitoneal balloon and exposure of the balloon spout but the balloon was not in¯ated. At the end of week 5, with IAP 25 mmHg above baseline, blood samples were drawn and the arterial and bladder pressures were measured. A pulmonary artery catheter was again placed for hemodynamic monitoring. The intraperitoneal balloon was then drained until the urinary bladder pressure was 10 mmHg above baseline. The following week the animals had their urinary bladder pressures recorded, blood samples drawn, and the intraperitoneal balloon drained until urinary bladder pressure was at baseline. At the end of the 7th week the animals underwent a ®nal non-survival procedure during which their urinary bladder pressures, systemic arterial pressures, central venous pressures, pulmonary artery pressures, pulmonary artery wedge pressures, and cardiac index were measured using the techniques previously described. The animals were sacri®ced with an overdose of pentobarbital.
Statistical analysis
Data are presented as meansAE SEM. Differences between and within groups were analyzed using analysis of variance (ANOVA) with Tukey's Studentized range test. Paired data were analyzed using a paired t-test. Statistical signi®cance was assumed for a P value less than 0.05.
Results
Effects of increasing intra-abdominal pressure
Weight.
There were no signi®cant changes in weight in either group during the course of the study beyond that accounted for by in¯ation of the intraperitoneal balloon with saline in the experimental group (Table 2) . However, there was a non-signi®cant decrease in net weight in the treated animals when the intra-abdominal balloon was in¯ated, followed by a non-signi®cant increase in weight after the balloon was de¯ated. Their urinary bladder pressures remained stable when remeasured the week following balloon in¯ation (Table 3) .
Hemodynamics.
Within the experimental group systolic arterial pressure rose progressively with increased IAP and was signi®cantly (P`0.05) elevated at IAP 25 mmHg when compared to their baseline (Figure 1) . Diastolic arterial pressure rose with elevated IAP, becoming signi®cantly (P`0.05) elevated at an IAP 25 mmHg when compared to their baseline (Figure 2) . When compared to the control group the systolic, mean and diastolic arterial pressures were all signi®cantly elevated at an IAP 15 mmHg above baseline. CI remained stable as IAP increased. SVRI, CVP, PAP and PAOP increased in response to increasing IAP, but none of these differences were statistically signi®cant (Table 4) .
Hormone and serum Na levels. PRA (3.4AE 0.8 to 2.8 AE 0.7 ngamlah), aldosterone concentration (15.4 AE 6.3 to 4.7 AE 1.7 ngadl), and ANP concentration (14.5 AE 9.1 to 3.2 AE 1.0 pgaml) did not change signi®cantly with rising IAP (Table 5) . Serum catecholamines were quite variable and were not signi®cantly changed from control values. Serum Na concentrations remained unchanged with increasing IAP (Table  3) . Because there were no signi®cant changes in the experimental group, the control samples were not analyzed. 
Effects of abdominal decompression
Hemodynamics.
Within the experimental group abdominal decompression was associated with a return of systolic ( Figure 1 ) and diastolic ( Figure 2 ) arterial pressures towards baseline levels.
Hormone and serum sodium levels. None of the hormone or sodium levels changed signi®cantly with abdominal decompression (Table 5 ).
Discussion
The mechanism by which elevated IAP produces systemic hypertension in this experimental model and in humans with central obesity is unclear. However, the most likely cause of hypertension in this animal model was an increase in peripheral vascular resistance, as cardiac output and weight remained stable and there were no changes in hormones likely to produce systemic hypertension.
We had hypothesized that there would be an alteration in renal hemodynamics with subsequent changes in salt and water balance secondary to several possible effects of an increased intra-abdominal pressure. First, increased renal venous pressure secondary to elevated IAP may be associated with an increased release of renin by the renin ± angiotensin ± aldosterone system and subsequent elevation in angiotensin IIaaldosterone concentrations and proteinuria. 20, 21 Second, elevated IAP causes a signi®cant increase in pleural pressure which, in turn, produces a signi®cant decrease in cardiac output. 22 The fraction of cardiac output presented to the kidneys, total renal blood¯ow and glomerular ®ltration rate all have been shown to decrease signi®cantly with elevated IAP. 23 ± 26 Elevated IAP also decreases cardiac output, and therefore renal perfusion, by decreasing venous return to the heart via inferior venal caval occlusion. 22 Chronic inferior vena caval constriction in dogs has been shown to cause reproducible hemodynamic abnormalities similar to those observed with elevated IAP and renal dysfunction characterized by increased PRA and aldosterone levels, decreased ANP, and marked Na and water retention. 27 ± 30 Lastly, direct renal compression, as occurs with elevated IAP, has been shown to elevate cortical pressures, placing the renal parenchyma at risk of ischemia, and causing renal dysfunction secondary to what one author called a`renal compartment syndrome'. 31, 32 In a study comparing human subjects with either central or peripheral obesity to each other and to a group of lean controls Scaglione et al found that renal blood and plasma¯ow were signi®cantly reduced. 33 They also noted that plasma renin activity, renal vascular resistance, and microalbuminuria were signi®cantly higher in persons with central obesity compared to those with peripheral obesity. Multiple regression analyses demonstrated that renal vascular resistance increased signi®cantly with increasing waist-to-hip ratio and plasma renin activity but not with changes in insulin levels. 33 Kolanowski has hypothesized that there is a resetting of`pressor naturesis' in obesity-induced hypertension which he suggests could be due to an increased reactivity to pressor factors such as an inadequate nitric oxide generation by vascular endothelium or increased sodium and calcium in vascular smooth muscle cells. 34 Hall and colleagues also postulate that increased tubular sodium reabsorption could be related to histological changes within the renal medulla, leading to compression of renal tubules and vasa recta, leading to a more ef®cient sodium reabsorption. 11 ± 13 It is just as reasonable to postulate that these effects are secondary to increased renal venous and renal capsular pressures.
We were disappointed when there were no signi®cant changes in hormone production by the renin ± angiotensin ± aldosterone system associated with rising IAP. 
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This does not necessarily mean that chronically elevated IAP does not affect the renin ± angiotensin ± aldosterone system. Blood samples were drawn only one day per week and this may not have been at the optimal time for the expected changes. Sampling several times per day or several days per week may have been more appropriate for detecting a change. Given the dog's natural upright posture, IAP may not have been distributed equally throughout the peritoneal cavity. Furthermore, the supine urinary bladder and systemic pressures recorded were not related to the animal's normal upright position.
Future studies of this model should have more frequent blood sampling as well as implanted arterial telemetric monitors in the axillary artery so that the animals can be continuously monitored, unanesthetized, with normal positions and activity.
Increased visceral metabolism and hyperinsulinemia could not have caused the hypertension in these animals since they did not have increased visceral adipose tissue and their weight remained reasonably stable during the period of study. Increased salt intake in experimental dogs also could not have caused the changes observed in blood pressure because both experimental and control dogs were fed the same standardized diet and, again, there was no signi®cant change in weight. The non-signi®cant decrease in weight in the experimental group when the balloon was in¯ated and increase when the balloon was de¯ated suggests that the experimental animals may not have eaten as well during the time of balloon in¯ation.
The possibility that pre-eclampsiaaeclampsia, or pregnancy induced hypertension (PIH), may be secondary to an increased IAP was ®rst broached in 1913 by Paramore. 35 Supporting this hypothesis is the fact that pregnancy induced PIH is more often seen with a ®rst pregnancy (when the abdomen has not been previously stretched) than subsequent pregnancies, 36 with twin pregnancies which would be more likely to be associated with an increased IAP, 36 and with severe obesity 37 which we have previously shown to have an increased IAP. 18 We hypothesize that increased IAP would activate the renin ± angiotensin ± aldosterone system, as previously discussed. However, as in this canine study of increased IAP, several studies have not found increased PRA in PIH, although one study did ®nd increased levels. 38 ± 41 Taken together these studies indicate that increased peripheral vascular resistance or altered renal hemodynamics caused by a rising IAP may be a more plausible pathophysiological cause of hypertension associated with central obesity and possibly preeclampsiaaeclampsia than metabolic changes secondary to increased visceral fat metabolism, hyperinsulinemia, and insulin induced sodium reabsorption and catecholamine release. ), systemic vascular resistance index (SVRI, dyne-sacm 5 am 2 ), central venous pressure (CVP mmHg), pulmonary artery pressure (PAP mmHg), and pulmonary artery occlusion pressure (PAOP mmHg) in control and experimental animals. None of these were signi®cantly different. Effects of increasing and decreasing intra-abdominal pressure on plasma renin activity (PRA, ngamlah), aldosterone (Aldo, ngadl), epinephrine (Epi, pgaml), nor-epinephrine (Nor-epi, pgaml), atrial natriuretic peptide (ANP, pgaml) and sodium (Na, mEqal) in experimental animals. None of these differences were signi®cantly different between groups.
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